Neogen Corporation (NASDAQ:NEOG) is a stock that investors should take a bite out of.

The price of Neogen Corporation (NASDAQ: NEOG) closed at $19.98 in the last session, up 1.83% from day before closing price of $19.62. In other words, the price has increased by $+0.36 from its previous closing price. On the day, 1850914 shares were traded. NEOG stock price reached its highest trading level at $20.06 during the session, while it also had its lowest trading level at $19.45.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…



We take a closer look at NEOG’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.30 and its Current Ratio is at 4.20. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.30.

Upgrades & Downgrades

On July 12, 2022, Piper Sandler started tracking the stock assigning a Neutral rating and target price of $25.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 13 when Jones Douglas Edward bought 2,500 shares for $17.91 per share. The transaction valued at 44,775 led to the insider holds 11,860 shares of the business.

Quinlan Steven J. bought 5,000 shares of NEOG for $58,150 on Oct 11. The VP & CFO now owns 32,722 shares after completing the transaction at $11.63 per share. On Oct 03, another insider, BOEHM WILLIAM T, who serves as the Director of the company, bought 2,000 shares for $13.88 each. As a result, the insider paid 27,770 and bolstered with 23,242 shares of the company.

Valuation Measures:

As of this moment, Neogen’s Price-to-Earnings (P/E) ratio for their current fiscal year is 454.09, and their Forward P/E ratio for the next fiscal year is 83.25. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 45.41. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.82 while its Price-to-Book (P/B) ratio in mrq is 1.39.

Stock Price History:

Over the past 52 weeks, NEOG has reached a high of $36.90, while it has fallen to a 52-week low of $10.49. The 50-Day Moving Average of the stock is 16.10, while the 200-Day Moving Average is calculated to be 20.01.

Shares Statistics:

According to the various share statistics, NEOG traded on average about 3.55M shares per day over the past 3-months and 2.98M shares per day over the past 10 days. A total of 216.13M shares are outstanding, with a floating share count of 215.80M. Insiders hold about 0.10% of the company’s shares, while institutions hold 93.50% stake in the company. Shares short for NEOG as of Oct 13, 2022 were 12.84M with a Short Ratio of 8.73M, compared to 20.94M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 5.94% and a Short% of Float of 6.68%.

Earnings Estimates

The company has 1 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.08 for the current quarter, with a high estimate of -$0.08 and a low estimate of -$0.08, while EPS last year was $0.1. The consensus estimate for the next quarter is -$0.04, with high estimates of -$0.04 and low estimates of -$0.04.

Analysts are recommending an EPS of between -$0.11 and -$0.11 for the fiscal current year, implying an average EPS of -$0.11. EPS for the following year is -$0.07, with 1 analysts recommending between -$0.07 and -$0.07.

Revenue Estimates

A total of 2 analysts have provided revenue estimates for NEOG’s current fiscal year. The highest revenue estimate was $862.4M, while the lowest revenue estimate was $834.73M, resulting in an average revenue estimate of $848.56M. In the same quarter a year ago, actual revenue was $527.16M, up 61.00% from the average estimate. Based on 2 analysts’ estimates, the company’s revenue will be $1.01B in the next fiscal year. The high estimate is $1.03B and the low estimate is $982.26M. The average revenue growth estimate for next year is up 18.60% from the average revenue estimate for this year.